Contaminate, Legislate, Repeat: How Disasters have Shaped our Pharma Regulatory Landscape
We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest. For further information on how we process and monitor your personal data click here.
The pharmaceuticals industry is one of the most tightly regulated industries on the planet, with many in the industry claiming that overregulation is stifling the industry and preventing the discovery of new, potentially life-saving medicines. It is important then to wonder how did we get here. Our editor examines the major cases which shaped the legislative landscape; from Sulfanilamide to the thalidomide tragedy, the major changes to regulation of the pharma industry have come following a high profile disaster. Read about these world-changing cases in Pharma IQ’s Contaminate, Legislate, Repeat.
Do we need to review our current legislation?
Is there a potential disaster waiting for us?
How can we find a balance between public safety and a successful pharmaceutical industry?
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.